METROPOLITAN LIFE INSURANCE CO/NY - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 86 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.6%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$71,572
+17.4%
3,493
+13.9%
0.00%
+33.3%
Q2 2023$60,961
+22.7%
3,068
+5.8%
0.00%0.0%
Q1 2023$49,677
-20.8%
2,900
-9.5%
0.00%0.0%
Q4 2022$62,722
+52.1%
3,205
+24.0%
0.00%
+50.0%
Q3 2022$41,241
+16.0%
2,5840.0%0.00%0.0%
Q2 2022$35,556
-13.2%
2,5840.0%0.00%
+100.0%
Q1 2022$40,982
-82.8%
2,584
-76.3%
0.00%
-66.7%
Q4 2021$237,620
-27.0%
10,8850.0%0.00%
-40.0%
Q3 2021$325,353
-32.5%
10,8850.0%0.01%
-28.6%
Q2 2021$482,097
+6.2%
10,885
+6.4%
0.01%0.0%
Q1 2021$453,994
-22.0%
10,232
-3.6%
0.01%
-22.2%
Q4 2020$582,181
+139.9%
10,6160.0%0.01%
+125.0%
Q3 2020$242,682
+9.2%
10,6160.0%0.00%0.0%
Q2 2020$222,193
+50.0%
10,6160.0%0.00%
+33.3%
Q1 2020$148,093
-38.7%
10,6160.0%0.00%
-25.0%
Q4 2019$241,620
+95.4%
10,6160.0%0.00%
+100.0%
Q3 2019$123,676
+1.8%
10,616
+31.1%
0.00%0.0%
Q2 2019$121,455
-6.5%
8,097
+9.4%
0.00%0.0%
Q1 2019$129,849
+18.4%
7,4030.0%0.00%0.0%
Q4 2018$109,712
-39.8%
7,4030.0%0.00%
-33.3%
Q3 2018$182,2627,4030.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
M28 Capital Management LP 523,280$10,722,00712.30%
RTW INVESTMENTS, LP 17,687,772$362,422,4487.65%
Logos Global Management LP 1,975,000$40,467,7505.40%
ACUTA CAPITAL PARTNERS, LLC 362,000$7,417,3804.97%
New Leaf Venture Partners, L.L.C. 118,242$2,422,7793.11%
MAVERICK CAPITAL LTD 5,629,970$115,358,0852.60%
Ghost Tree Capital, LLC 295,000$6,044,5501.99%
Frazier Life Sciences Management, L.P. 1,403,013$28,747,7361.91%
Ikarian Capital, LLC 654,726$13,415,3351.61%
Boxer Capital, LLC 1,466,051$30,039,3851.60%
View complete list of ROCKET PHARMACEUTICALS INC shareholders